Two healthcare plans have joined the ranks of those suing Big Pharma heavyweights over their alleged contributions to the national opioid crisis that has devastated the nation.
Rite Aid Corporation has been hit with a proposed class action in California that claims the drugstore chain collects donations from customers without their consent.
Mylan and Rite Aid are facing a class action that claims the companies respectively manufactured and sold generic valsartan medications despite possessing knowledge that the drugs were contaminated with probable carcinogen N-nitrosodiethylamine (NDEA).
Rite Aid Corporation is facing another proposed class action alleging it engineered an 'unfair and deceptive price scheme' to overcharge customers paying for generic drugs through third-party insurance plans.
According to a recent class action, Rite Aid runs a deceptive pricing scheme in which it undercuts the 'usual and customary' prices for generic drugs.